Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00757666 · ClinicalTrials.gov registry record · NA
APPROPRIATE - Rate Adaptive Pacing Sensor
A NA study, sponsored by Boston Scientific Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 566
- Enrollment target
NCT00757666 is a NA study that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 566 participants.
The verdict
NCT00757666, a NA study, was terminated before completion, sponsored by Boston Scientific Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 566 participants
- Enrollment target
Study Summary
The APPROPRIATE study will compare differences in functional capacity (peak VO2) between chronotropically incompetent patients randomized to receive rate responsive pacing driven by either the minute ventilation (respiration-based) sensor or an accelerometer (motion-based).
Interventions
- DEVICE Rate adaptive pacemaker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 566 participants |
| Start Date | 2008-12 |
| Est. Completion | 2011-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00757666
The ClinicalTrials.gov registry entry for NCT00757666 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 566 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rate adaptive pacemaker is the first listed.
NCT00757666 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00757666 about?
NCT00757666 is a clinical study titled "APPROPRIATE - Rate Adaptive Pacing Sensor". The APPROPRIATE study will compare differences in functional capacity (peak VO2) between chronotropically incompetent patients randomized to receive rate responsive pacing driven by either the minute ventilation (respiration-based) sensor or an accelerometer (motion-based).
What is the current status of trial NCT00757666?
This trial is currently terminated. It is a NA study. The enrollment target is 566 participants. The study started on 2008-12. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00757666?
The interventions under investigation include: Rate adaptive pacemaker (DEVICE).
Who is sponsoring clinical trial NCT00757666?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.